Truth short folly

Somebody, using the name “Jen Lehman” has recently unlawfully pretended to represent “Study in Poland” recruiting students to Polish universities. Beware the person HAS NO RIGHT to use or refer to website

Browse from more than 400 English study programmes in Poland!

Excellence put unaffected


Nay particular delightful

Academic schools

Vocational schools

Study in Poland - programme -

SGH Warsaw School of Economics

address: al. Niepodległości 162
02-554 Warsaw, Poland
phone: +48 22 564 98 58
e-mail: [email protected]    internet:

MA in International Tourism, Hotel Industry and Leisure Services




2 years


The second-cycle studies in International Tourism, Hotel Industry and Leisure Services at the Warsaw School of Economics aim to equip students with appropriate knowledge and skills for business activities in the area of tourism and leisure services.
Graduates of the major may pursue career in hotel industry, travel agencies, entities rendering recreation and entertainment services, and in other enterprises operating in the tourist market environment. They may also pursue career in public administration institutions, NGOs, and entities specializing in consultancy, tourist market research and leisure services research. The studies also prepare students to establish their own businesses and to take up the third-cycle studies.


1800 EUR per semester


Contact the Unit


al. Niepodległości 162
office 37, building G
02-554 Warsaw
phone.: + 48 22 564 77 77
e-mail: [email protected]



al. Niepodległości 162 office 37, building G 02-554 Warsaw, Poland phone: +48 22 564 77 77 e-mail: [email protected]

education requirements

Programmes in foreign languages are conducted only as full-time studies.
The enrolment has following stages:
registration in the online system
submission of required documents
end of submission of documents period
verification of documents by SGH
issuing decissions on admission
information about registration for classes sent by Master Dean's Office (in the registration system) more:

The main criterion for them is your ability to repay any , they are not interested in your previous attempts, the current one is all that matters. On the global pharmaceutical market this medicine was issued in 2003 by two companies - Eli Lilly and ICOS. Initially, permission to sell was obtained in Europe, Australia, New Zealand.